Belgium Lipid Market Size & Outlook, 2022-2030

The lipid market in Belgium is expected to reach a projected revenue of US$ 237.2 million by 2030. A compound annual growth rate of 5.5% is expected of Belgium lipid market from 2023 to 2030.
Revenue, 2022 (US$M)
$154.4
Forecast, 2030 (US$M)
$237.2
CAGR, 2023 - 2030
5.5%
Report Coverage
Belgium

Belgium lipid market highlights

  • The Belgium lipid market generated a revenue of USD 154.4 million in 2022 and is expected to reach USD 237.2 million by 2030.
  • The Belgium market is expected to grow at a CAGR of 5.5% from 2023 to 2030.
  • In terms of segment, clinical was the largest revenue generating phase in 2022.
  • Clinical is the most lucrative phase segment registering the fastest growth during the forecast period.


Lipid market data book summary

Market revenue in 2022USD 154.4 million
Market revenue in 2030USD 237.2 million
Growth rate5.5% (CAGR from 2022 to 2030)
Largest segmentClinical
Fastest growing segmentClinical
Historical data2018 - 2021
Base year2022
Forecast period2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationClinical, Pre-clinical
Key market players worldwideDanaher Corp, Evonik Industries AG, Merck KGaA, Croda International PLC, Lipoid, Cargill, Basf SE, Archer-Daniels Midland Co, Koninklijke DSM NV, Kerry Group PLC Class A, Nordic Naturals, Fiserv Inc, Omega Protein


Other key industry trends

  • In terms of revenue, Belgium accounted for 1.6% of the global lipid market in 2022.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, Germany lipid market is projected to lead the regional market in terms of revenue in 2030.
  • Germany is the fastest growing regional market in Europe and is projected to reach USD 609.3 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Lipid Market Companies

Name Profile # Employees HQ Website

Belgium lipid market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to lipid market will help companies and investors design strategic landscapes.


Clinical was the largest segment with a revenue share of 18.46% in 2022. Horizon Databook has segmented the Belgium lipid market based on clinical, pre-clinical covering the revenue growth of each sub-segment from 2018 to 2030.


Belgium is among the prominent (bio)pharmaceutical markets in Europe. According to pharma.be (General Association of the Pharmaceutical Industry), Belgium was one of the prominent R&D spenders in the European pharmaceutical and biomedical sector. 

The government aims to reinforce the country’s position as a strong ‘health and biotech valley’ in Europe. The increasing investment in various R&D activities in the field of (bio)pharmaceuticals in the country coupled with government support to strengthen the country’s position in the global pharmaceutical sector is expected to drive the lipid market over the coming years.

In addition to the robust pharmaceutical industry, Belgium is also known for its chocolate and chocolate products. The well-established chocolate industry in Belgium coupled with the increasing usage of lipids in the chocolate industry is expected to drive the market.

Reasons to subscribe to Belgium lipid market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Belgium lipid market databook

  • Our clientele includes a mix of lipid market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Belgium lipid market , including forecasts for subscribers. This country databook contains high-level insights into Belgium lipid market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Belgium lipid market size, by phase, 2018-2030 (US$M)

Belgium Lipid Market Outlook Share, 2022 & 2030 (US$M)

Belgium lipid market size, by phase, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more